Can you confirm this is true? Richards said: "Dr. Williams, one of our biotech consultants, has added 500,000 shares to his position in KERX this month as he was encouraged by the delay in the 360 event and believes KERX will trade upwards of $10 this year. Dr. Williams also owns 1.2 million shares of AEZS. We value his opinion immensely and his track record is impeccable. Most notably, he invested in Dendreon (DNDN) at under $4 a share in 2006 when it was out of favor with the Street and sold it at $50 in 2010. Dr. Wurlitzer, a well-respected surgical oncologist and former surgical instructor at a major university, now owns approximately one million shares of AEZS as he firmly believes in the success of Perifosine..."